Norbert Scherbaum
Impact in
- Toxicology top 0.1%
- Forensic Toxicology and Drug Analysis
Papers in
-
- Attention Deficit Hyperactivity Disorder 16
- Schizophrenia research and treatment 13
-
- Opioid Use Disorder Treatment 37
- Co-authors
- Udo Bonnet (60 shared papers)Michael Specka (62 shared papers)Markus Gastpar (25 shared papers)Fabrizio Schifano (34 shared papers)Bernhard Müller (18 shared papers)Jens Wiltfang (20 shared papers)Peter Kienbaum (9 shared papers)John Corkery (10 shared papers)
- Journals
- Pharmacopsychiatry (15 papers)Frontiers in Psychiatry (13 papers)European Addiction Research (8 papers)European Psychiatry (6 papers)PLoS ONE (5 papers)
- Partner nations
- GermanyUnited KingdomItaly
In The Last Decade
Norbert Scherbaum
264 papers receiving 4.1k citations
Peers
Comparison fields: 5 of 154
- Toxicology 595
- Anesthesiology and Pain Medicine 222
- Clinical Psychology 757
- Biological Psychiatry 85
- Psychiatry and Mental health 468
Countries citing papers authored by Norbert Scherbaum
This map shows the geographic impact of Norbert Scherbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norbert Scherbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norbert Scherbaum more than expected).
Fields of papers citing papers by Norbert Scherbaum
This network shows the impact of papers produced by Norbert Scherbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norbert Scherbaum. The network helps show where Norbert Scherbaum may publish in the future.
Co-authors
The 25 scholars most cited alongside Norbert Scherbaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 291 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 251 | |
| 2 | 2017 | 209 | |
| 3 | 2012 | 140 | |
| 4 | 2013 | 106 | |
| 5 | 2020 | 92 | |
| 6 | 1996 | 78 | |
| 7 | 2012 | 73 | |
| 8 | 2019 | 72 | |
| 9 | 2008 | 68 | |
| 10 | 1995 | 66 | |
| 11 | 2011 | 63 | |
| 12 | 1998 | 62 | |
| 13 | 2020 | 59 | |
| 14 | 2010 | 58 | |
| 15 | 2008 | 55 | |
| 16 | 2009 | 55 | |
| 17 | 2012 | 48 | |
| 18 | 2000 | 46 | |
| 19 | 2014 | 45 | |
| 20 | 2018 | 44 |
About Norbert Scherbaum
Norbert Scherbaum is a scholar working on Psychiatry and Mental health, Public Health, Environmental and Occupational Health, Clinical Psychology, Epidemiology and Pharmacology, having authored 291 papers that have together received 4.3k indexed citations. Recurring topics across this work include Opioid Use Disorder Treatment (37 papers), Substance Abuse Treatment and Outcomes (30 papers), Cannabis and Cannabinoid Research (16 papers), Attention Deficit Hyperactivity Disorder (16 papers), Neurotransmitter Receptor Influence on Behavior (15 papers), Forensic Toxicology and Drug Analysis (14 papers), Schizophrenia research and treatment (13 papers) and Mental Health Treatment and Access (11 papers). The work is most often cited by research in Toxicology (595 citations), Anesthesiology and Pain Medicine (222 citations), Clinical Psychology (757 citations), Biological Psychiatry (85 citations) and Psychiatry and Mental health (468 citations). Norbert Scherbaum has collaborated with scholars based in Germany, United Kingdom and Italy. Frequent co-authors include Udo Bonnet, Michael Specka, Markus Gastpar, Fabrizio Schifano, Bernhard Müller, Jens Wiltfang, Peter Kienbaum, John Corkery, Holger Siemann and Jürgen Peters. Their work appears in journals such as Pharmacopsychiatry, Frontiers in Psychiatry, European Addiction Research, European Psychiatry and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.